Browsing by Author Sanchez-Parada, M.G.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 8 of 8
TitleAuthor(s)???itemlist.dc.contributor.other??????itemlist.dc.contributor.editor???
A controlled clinical trial with pirfenidone in the treatment of pathological skin scarring caused by burns in pediatric patientsArmendariz-Borunda, J.; Lyra-Gonzalez, I.; Medina-Preciado, D.; Gonzalez-Garcia, I.; Martinez-Fong, D.; Miranda, R.A.; Magana-Castro, R.; Pena-Santoyo, P.; Garcia-Rocha, S.; Bautista, C.A.; Godoy, J.; Flores-Montana, J.; Floresvillar-Mosqueda, J.; Armendariz-Vazquez, O.; Lucano-Landeros, M.S.; Vazquez-Del Mercado, M.; Sanchez-Parada, M.G.--
A controlled clinical trial with pirfenidone in the treatment of pathological skin scarring caused by burns in pediatric patientsArmendariz-Borunda, J.; Lyra-Gonzalez, I.; Medina-Preciado, D.; Gonzalez-Garcia, I.; Martinez-Fong, D.; Miranda, R.A.; Magana-Castro, R.; Pena-Santoyo, P.; Garcia-Rocha, S.; Bautista, C.A.; Godoy, J.; Flores-Montana, J.; Floresvillar-Mosqueda, J.; Armendariz-Vazquez, O.; Lucano-Landeros, M.S.; Vazquez-Del Mercado, M.; Sanchez-Parada, M.G.--
Controlled clinical trial with pirfenidone in the treatment of breast capsular contracture: Association of TGF-? polymorphismsVeras-Castillo, E.R.; Cardenas-Camarena, L.; Lyra-Gonzalez, I.; Munoz-Valle, J.F.; Lucano-Landeros, S.; Guerrerosantos, J.; Gonzalez-Ulloa, B.; Mercado-Barajas, J.L.; Sanchez-Parada, M.G.; Azabache-Wennceslao, R.; Armendariz-Borunda, J.--
Controlled clinical trial with pirfenidone in the treatment of breast capsular contracture: Association of TGF-β polymorphismsVeras-Castillo, E.R.; Cardenas-Camarena, L.; Lyra-Gonzalez, I.; Munoz-Valle, J.F.; Lucano-Landeros, S.; Guerrerosantos, J.; Gonzalez-Ulloa, B.; Mercado-Barajas, J.L.; Sanchez-Parada, M.G.; Azabache-Wennceslao, R.; Armendariz-Borunda, J.--
Genotoxic evaluation of pirfenidone using erythrocyte rodent micronucleus assayAlcantar-Diaz, B.E.; Gomez-Meda, B.C.; Zuniga-Gonzalez, G.M.; Zamora-Perez, A.L.; Gonzalez-Cuevas, J.; Alvarez-Rodriguez, B.A.; Sanchez-Parada, M.G.; Garcia-Banuelos, J.J.; Armendariz-Borunda, J.--
Genotoxic evaluation of pirfenidone using erythrocyte rodent micronucleus assayAlcantar-Diaz, B.E.; Gomez-Meda, B.C.; Zuniga-Gonzalez, G.M.; Zamora-Perez, A.L.; Gonzalez-Cuevas, J.; Alvarez-Rodriguez, B.A.; Sanchez-Parada, M.G.; Garcia-Banuelos, J.J.; Armendariz-Borunda, J.--
Treatment with pirfenidone for two years decreases fibrosis, cytokine levels and enhances CB2 gene expression in patients with chronic hepatitis CFlores-Contreras, L.; Sandoval-Rodriguez, A.S.; Mena-Enriquez, M.G.; Lucano-Landeros, S.; Arellano-Olivera, I.; Alvarez-Alvarez, A.; Sanchez-Parada, M.G.; Armendariz-Borunda, J.--
Treatment with pirfenidone for two years decreases fibrosis, cytokine levels and enhances CB2 gene expression in patients with chronic hepatitis CFlores-Contreras, L.; Sandoval-Rodriguez, A.S.; Mena-Enriquez, M.G.; Lucano-Landeros, S.; Arellano-Olivera, I.; Alvarez-Alvarez, A.; Sanchez-Parada, M.G.; Armendariz-Borunda, J.--